Adaptation of Pseudomonas aeruginosa clinical isolates to benzalkonium chloride retards its growth and enhances biofilm production
- 41 Downloads
The increasing percentage of Pseudomonas aeruginosa strains that are resistant to multiple antibiotics is a global problem. The exposure of P. aeruginosa isolates to repeated sub lethal concentrations of biocides in hospitals and communities may be one of the causes leading to increased antibiotic resistance. Benzalkonium chloride (BAC) is widely used as disinfectant and preservative. This study investigated the effect of exposure of P. aeruginosa clinical isolates to sub lethal concentrations of BAC on their antibiotic resistance, growth process and biofilm formation. The collected 43 P. aeruginosa clinical isolates were daily subjected to increasing sub lethal concentrations of BAC. The effect of adaptation on antibiotic resistance, growth process, cell surface hydrophobicity and biofilm formation of P. aeruginosa isolates were examined. Interestingly, Most P. aeruginosa isolates adapted to BAC showed an increase in antibiotic resistance and 66% of the isolates showed retardation of growth, 63% showed increased cell surface hydrophobicity and 23.5% exhibited enhanced biofilm formation by crystal violet assay. To define whether the effect of BAC adaptation on biofilm production was manifested at the transcriptional level, quantitative RT-PCR was used. We found that 60% of the tested isolates showed overexpression of ndvB biofilm gene. More efforts are required to diminish the increasing use of BAC to avoid bacterial adaptation to this biocide with subsequent retardation of growth and enhanced biofilm formation which could lead to antibiotic resistance and treatment failure of infections caused by this opportunistic pathogen.
KeywordsAdaptation Antibiotic resistance Benzalkonium chloride Biofilm formation Growth Pseudomonas aeruginosa
Compliance with ethical standards
Conflict of interest
The authors declare that the research was conducted in the absence of any conflict of interest.
- 2.El Banna T, Sonbol F, Abd El Aziz A, Elekhnawy E (2015) Characterization of vancomycin resistant Staphylococcus aureus in Tanta university hospital. Int J Curr Microbiol App Sci 4:1–11Google Scholar
- 4.Deep A, Chaudhary A, Gupta V (2011) Quorum sensing and bacterial pathogenicity: from molecules to disease. J Lab Phys 3:4–11Google Scholar
- 9.MacFaddin JF (1976) Biochemical tests for identification of medical bacteria. Williams & Wilkins Co., BaltimoreGoogle Scholar
- 10.Clinical and Laboratory Standards Institute (CLSI) (2017) Performance standards for antimicrobial susceptibility testing. Wayne, PennsylvaniaGoogle Scholar
- 16.Sonbol F, El-Banna T, Abd El-Aziz A, El-Ekhnawy E (2018) Biological characters of vancomycin resistant Staphylococcus aureus isolates from a university hospital in Egypt. Arch Clin Microbial 9:72Google Scholar
- 22.Fernández-Cuenca F, Tomás M, Caballero-Moyano F, Bou G, Martínez L, Vila J et al (2015) Reduced susceptibility to biocides in Acinetobacter baumannii: association with resistance to antimicrobials, epidemiological behaviour, biological cost and effect on the expression of genes encoding porins and efflux pumps. J Antimicrob Chemother 70:3222–3229CrossRefGoogle Scholar
- 25.Capita R, Riesco-Peláez F, Alonso-Hernando A, Alonso-Calleja C (2014) Exposure of Escherichia coli ATCC 12806 to sublethal concentrations of food-grade biocides influences its ability to form biofilm, resistance to antimicrobials, and ultrastructure. Appl Environ Microbiol 80(4):1268–1280CrossRefGoogle Scholar
- 31.Elbanna T, Sonbol S, Abdelaziz A, Elekhnawy E (2015) Increased biofilm production associated with increasing vancomycin MICs among vancomycin resistant staphylococci. Inventi 4:1–4Google Scholar
- 44.Grela E, Ząbek A, Grabowiecka A (2015) Interferences in the optimization of the MTT assay for viability estimation of Proteus mirabilis. Avicenna J Med Biotech 7:159–167Google Scholar